| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.079 | 0.3 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.3 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |